Literature DB >> 1563320

Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis.

P Arveux1, J Faivre, M C Boutron, F Piard, L Dusserre-Guion, E Monnet, P Hillon.   

Abstract

A population-based series of 246 gastric cancer patients operated for cure and who survived the postoperative phase was reviewed to determine prognostic factors after potentially curative treatment. The overall five-year observed survival rate was 34.8%, and the relative survival rate was 43.9%. Previous history of gastric ulceration, tumor location, tumor size, gross appearance, extension within the gastric wall, and number of proximal lymph nodes involved were significantly related to both crude and relative survival rates. Age was a significant prognostic factor when considering crude survival rates, but it had no influence on relative survival rates. Multivariate analysis of crude and relative survival gave similar results except for age. The covariates retained in the final model were, by decreasing importance, extension within the gastric wall, lymph node involvement, gross appearance and tumor location. Combining the two major prognostic criteria, tumor extension through the gastric wall and lymph node involvement, four prognostic categories could be determined with five-year corrected survival rates ranging from 92% in patients with a carcinoma limited to the gastric wall to 17% in patients with more than two positive nodes whatever the extension in the gastric wall. Gross appearance had no influence on prognosis for carcinomas limited to the gastric wall, but had a significant impact on prognosis of more extended carcinomas. From these data, a simple staging system requiring only routinely available pathological data was proposed. This classification could be helpful for planning multicenter clinical trials on this disease where progress in therapy is needed.

Entities:  

Mesh:

Year:  1992        PMID: 1563320     DOI: 10.1007/bf01296435

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

Review 1.  [Gastric adenocarcinoma surgically treated. A multivariate analysis of prognostic factors].

Authors:  D Elias; P H Lasser; C Bognel; J M Nadal; K Rahal; R Pineda; P Rougier
Journal:  Gastroenterol Clin Biol       Date:  1988-10

2.  Relative survival and the estimation of net survival: elements for further discussion.

Authors:  J Estève; E Benhamou; M Croasdale; L Raymond
Journal:  Stat Med       Date:  1990-05       Impact factor: 2.373

3.  Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: a multivariate analysis.

Authors:  S Msika; C Chastang; S Houry; F Lacaine; M Huguier
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

4.  Survival of cancer patients in Finland in 1953-1974.

Authors:  T Hakulinen; E Pukkala; M Hakama; M Lehtonen; E Saxén; L Teppo
Journal:  Ann Clin Res       Date:  1981

5.  Factors influencing survival in patients with cancer of the stomach. A multivariate analysis.

Authors:  O Søreide; J Lillestøl; A Viste; T Bjerkeset
Journal:  Acta Chir Scand       Date:  1982

6.  Gastric carcinoma in Côte d'Or (France). A population-based study.

Authors:  J Faivre; E Justrabo; P Hillon; C Milan; C Klepping
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

7.  Gastric cancer: a 25-year review.

Authors:  W H Allum; D J Powell; C C McConkey; J W Fielding
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

8.  A computer program package for relative survival analysis.

Authors:  T Hakulinen; K H Abeywickrama
Journal:  Comput Programs Biomed       Date:  1985

9.  A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection.

Authors:  F Bozzetti; G Bonfanti; A Morabito; R Bufalino; V Menotti; S Andreola; R Doci; L Gennari
Journal:  Surg Gynecol Obstet       Date:  1986-03
  9 in total
  9 in total

1.  Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; A F Li; W Y Lui; F K P'eng
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; W Y Lui; F K P'eng
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Clinicopathological analysis of Borrmann type IV gastric cancer.

Authors:  Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

5.  Comparison of colorectal and gastric cancer: survival and prognostic factors.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

6.  Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies.

Authors:  Domenico D'Ugo; Fabio Pacelli; Roberto Persiani; Vito Pende; Andrea Ianni; Valerio Papa; Giovanni Battista Doglietto; Aurelio Picciocchi
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

7.  Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experience.

Authors:  Rieko Nakamura; Yoshiro Saikawa; Norihito Wada; Masashi Yoshida; Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2007-08-20       Impact factor: 3.402

8.  Application of smoothing methods for determining of the effecting factors on the survival rate of gastric cancer patients.

Authors:  Hoda Noorkojuri; Ebrahim Hajizadeh; Ahmadreza Baghestani; Mohamadamin Pourhoseingholi
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

9.  Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.

Authors:  C C Yu; D A Levison; J A Dunn; L C Ward; M Demonakou; W H Allum; M T Hallisey
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.